Received Mar 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | UNK | X01182 | — |
No adverse side effects were reported.; HCP calling to inquire about a pediatric RECOMBIVAX HB vaccine that was administered to an adult, and if they can revaccinate with another pediatric dose, see request case 02752180. HCP refused to provide patient information at the time of the call.; This spontaneous report was received from a nurse practitioner concerning an adult patient of unspecified gender. The patient's medical history, concurrent conditions, concomitant therapies and drug reactions/allergies were not reported. On 11-FEB-2025, the patient was vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), Injection, batch# reported as X01182 which is an invalid batch/lot number for Hepatitis B Vaccine (Recombinant), expiration date reported as 01-OCT-2025) 1 dosage form (pediatric dose) (dosage regimen, anatomical location and route of administration were not provided) administered as prophylaxis (underdose.) The reporter inquired if they could revaccinate with another pediatric dose. No adverse side effects were reported (no adverse event). No additional information available.